207 related articles for article (PubMed ID: 22004065)
1. Radioprotection by hymenialdisine-derived checkpoint kinase 2 inhibitors.
Nguyen TN; Saleem RS; Luderer MJ; Hovde S; Henry RW; Tepe JJ
ACS Chem Biol; 2012 Jan; 7(1):172-84. PubMed ID: 22004065
[TBL] [Abstract][Full Text] [Related]
2. Ionizing radiation activates the ATM kinase throughout the cell cycle.
Pandita TK; Lieberman HB; Lim DS; Dhar S; Zheng W; Taya Y; Kastan MB
Oncogene; 2000 Mar; 19(11):1386-91. PubMed ID: 10723129
[TBL] [Abstract][Full Text] [Related]
3. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
[TBL] [Abstract][Full Text] [Related]
4. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
5. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
6. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner.
Gibson SL; Bindra RS; Glazer PM
Cancer Res; 2005 Dec; 65(23):10734-41. PubMed ID: 16322218
[TBL] [Abstract][Full Text] [Related]
8. Potent inhibition of checkpoint kinase activity by a hymenialdisine-derived indoloazepine.
Sharma V; Tepe JJ
Bioorg Med Chem Lett; 2004 Aug; 14(16):4319-21. PubMed ID: 15261294
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2.
Carlessi L; Buscemi G; Larson G; Hong Z; Wu JZ; Delia D
Mol Cancer Ther; 2007 Mar; 6(3):935-44. PubMed ID: 17363488
[TBL] [Abstract][Full Text] [Related]
10. Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM.
Dauth I; Krüger J; Hofmann TG
Cancer Res; 2007 Mar; 67(5):2274-9. PubMed ID: 17332358
[TBL] [Abstract][Full Text] [Related]
11. Gamma-radiation-induced ATM-dependent signalling in human T-lymphocyte leukemic cells, MOLT-4.
Tichý A; Záskodová D; Rezácová M; Vávrová J; Vokurková D; Pejchal J; Vilasová Z; Cerman J; Osterreicher J
Acta Biochim Pol; 2007; 54(2):281-7. PubMed ID: 17565390
[TBL] [Abstract][Full Text] [Related]
12. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
Falck J; Mailand N; Syljuåsen RG; Bartek J; Lukas J
Nature; 2001 Apr; 410(6830):842-7. PubMed ID: 11298456
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of debromohymenialdisine-derived Chk2 inhibitors.
Saleem RS; Lansdell TA; Tepe JJ
Bioorg Med Chem; 2012 Feb; 20(4):1475-81. PubMed ID: 22285028
[TBL] [Abstract][Full Text] [Related]
14. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.
Falck J; Lukas C; Protopopova M; Lukas J; Selivanova G; Bartek J
Oncogene; 2001 Sep; 20(39):5503-10. PubMed ID: 11571648
[TBL] [Abstract][Full Text] [Related]
15. Constitutive phosphorylation of ATM in lymphoblastoid cell lines from patients with ICF syndrome without downstream kinase activity.
Goldstine JV; Nahas S; Gamo K; Gartler SM; Hansen RS; Roelfsema JH; Gatti RA; Marahrens Y
DNA Repair (Amst); 2006 Apr; 5(4):432-43. PubMed ID: 16426903
[TBL] [Abstract][Full Text] [Related]
16. Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles.
Arienti KL; Brunmark A; Axe FU; McClure K; Lee A; Blevitt J; Neff DK; Huang L; Crawford S; Pandit CR; Karlsson L; Breitenbucher JG
J Med Chem; 2005 Mar; 48(6):1873-85. PubMed ID: 15771432
[TBL] [Abstract][Full Text] [Related]
17. Bowman-Birk protease inhibitor activates DNA-dependent protein kinase and reduces formation of radiation-induced dicentric chromosomes.
Dittmann K; Virsik-Köpp P; Mayer C; Rave-Fränk M; Rodemann HP
Int J Radiat Biol; 2003 Oct; 79(10):801-8. PubMed ID: 14630539
[TBL] [Abstract][Full Text] [Related]
18. Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response.
Jack MT; Woo RA; Hirao A; Cheung A; Mak TW; Lee PW
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9825-9. PubMed ID: 12097646
[TBL] [Abstract][Full Text] [Related]
19. The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe.
Castedo M; Perfettini JL; Roumier T; Yakushijin K; Horne D; Medema R; Kroemer G
Oncogene; 2004 May; 23(25):4353-61. PubMed ID: 15048074
[TBL] [Abstract][Full Text] [Related]
20. Replication protein A2 phosphorylation after DNA damage by the coordinated action of ataxia telangiectasia-mutated and DNA-dependent protein kinase.
Wang H; Guan J; Wang H; Perrault AR; Wang Y; Iliakis G
Cancer Res; 2001 Dec; 61(23):8554-63. PubMed ID: 11731442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
